Literature DB >> 26551701

Dual regulation of transcription factor Nrf2 by Keap1 and by the combined actions of β-TrCP and GSK-3.

John D Hayes1, Sudhir Chowdhry2, Albena T Dinkova-Kostova2, Calum Sutherland3.   

Abstract

Nuclear factor-erythroid 2 p45 (NF-E2 p45)-related factor 2 (Nrf2) is a master regulator of redox homoeostasis that allows cells to adapt to oxidative stress and also promotes cell proliferation. In this review, we describe the molecular mechanisms by which oxidants/electrophilic agents and growth factors increase Nrf2 activity. In the former case, oxidants/electrophiles increase the stability of Nrf2 by antagonizing the ability of Kelch-like ECH-associated protein 1 (Keap1) to target the transcription factor for proteasomal degradation via the cullin-3 (Cul3)-RING ubiquitin ligase CRL(Keap1). In the latter case, we speculate that growth factors increase the stability of Nrf2 by stimulating phosphoinositide 3-kinase (PI3K)-protein kinase B (PKB)/Akt signalling, which in turn results in inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) and in doing so prevents the formation of a DSGIS motif-containing phosphodegron in Nrf2 that is recognized by the β-transducin repeat-containing protein (β-TrCP) Cul1-based E3 ubiquitin ligase complex SCF(β-TrCP). We present data showing that in the absence of Keap1, the electrophile tert-butyl hydroquinone (tBHQ) can stimulate Nrf2 activity and induce the Nrf2-target gene NAD(P)H: quinone oxidoreductase-1 (NQO1), whilst simultaneously causing inhibitory phosphorylation of GSK-3β at Ser(9). Together, these observations suggest that tBHQ can suppress the ability of SCF(β-TrCP) to target Nrf2 for proteasomal degradation by increasing PI3K-PKB/Akt signalling. We also propose a scheme that explains how other protein kinases that inhibit GSK-3 could stimulate induction of Nrf2-target genes by preventing formation of the DSGIS motif-containing phosphodegron in Nrf2.
© 2015 Authors; published by Portland Press Limited.

Entities:  

Keywords:  NF-E2 p45-related factor 2 (Nrf2); epidermal growth factor; glycogen synthase kinase-3 (GSK-3); keratinocyte growth factor; phosphoinositide 3-kinase (PI3K); protein kinase B (PKB)/Akt; β-transducin repeat-containing protein (β-TrCP)

Mesh:

Substances:

Year:  2015        PMID: 26551701     DOI: 10.1042/BST20150011

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  46 in total

1.  Withaferin A Improves Nonalcoholic Steatohepatitis in Mice.

Authors:  Daxesh P Patel; Tingting Yan; Donghwan Kim; Henrique B Dias; Kristopher W Krausz; Shioko Kimura; Frank J Gonzalez
Journal:  J Pharmacol Exp Ther       Date:  2019-08-16       Impact factor: 4.030

2.  Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation.

Authors:  Tihomir Miralem; Nicole Lerner-Marmarosh; Peter E M Gibbs; Jermaine L Jenkins; Chelsea Heimiller; Mahin D Maines
Journal:  FASEB J       Date:  2016-05-10       Impact factor: 5.191

3.  Nrf2 Activation Inhibits Effects of Thrombin in Human Amnion Cells and Thrombin-Induced Preterm Birth in Mice.

Authors:  Yoshitsugu Chigusa; Annavarapu Hari Kishore; Haruta Mogami; Ruth Ann Word
Journal:  J Clin Endocrinol Metab       Date:  2016-04-06       Impact factor: 5.958

4.  Uranium-induced rat kidney cell cytotoxicity is mediated by decreased endogenous hydrogen sulfide (H2S) generation involved in reduced Nrf2 levels.

Authors:  Yan Yuan; Jifang Zheng; Tingting Zhao; Xiaoqing Tang; Nan Hu
Journal:  Toxicol Res (Camb)       Date:  2016-01-27       Impact factor: 3.524

5.  The role of natural products in revealing NRF2 function.

Authors:  Donna D Zhang; Eli Chapman
Journal:  Nat Prod Rep       Date:  2020-05-13       Impact factor: 13.423

6.  Free heme regulates placenta growth factor through NRF2-antioxidant response signaling.

Authors:  Maria G Kapetanaki; Oluwabukola T Gbotosho; Deva Sharma; Frances Weidert; Solomon F Ofori-Acquah; Gregory J Kato
Journal:  Free Radic Biol Med       Date:  2019-08-10       Impact factor: 7.376

Review 7.  Parkinson's disease, aging and adult neurogenesis: Wnt/β-catenin signalling as the key to unlock the mystery of endogenous brain repair.

Authors:  Bianca Marchetti; Cataldo Tirolo; Francesca L'Episcopo; Salvatore Caniglia; Nunzio Testa; Jayden A Smith; Stefano Pluchino; Maria F Serapide
Journal:  Aging Cell       Date:  2020-02-12       Impact factor: 9.304

8.  Diosmetin induces apoptosis and enhances the chemotherapeutic efficacy of paclitaxel in non-small cell lung cancer cells via Nrf2 inhibition.

Authors:  Xiangcui Chen; Qipeng Wu; Yueming Chen; Jiahao Zhang; Huachao Li; Zhicheng Yang; Yang Yang; Yanchao Deng; Luyong Zhang; Bing Liu
Journal:  Br J Pharmacol       Date:  2019-05-11       Impact factor: 8.739

9.  Withaferin A induces Nrf2-dependent protection against liver injury: Role of Keap1-independent mechanisms.

Authors:  Dushani L Palliyaguru; Dionysios V Chartoumpekis; Nobunao Wakabayashi; John J Skoko; Yoko Yagishita; Shivendra V Singh; Thomas W Kensler
Journal:  Free Radic Biol Med       Date:  2016-10-04       Impact factor: 7.376

Review 10.  Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease.

Authors:  Lauren E Tebay; Holly Robertson; Stephen T Durant; Steven R Vitale; Trevor M Penning; Albena T Dinkova-Kostova; John D Hayes
Journal:  Free Radic Biol Med       Date:  2015-06-27       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.